NCT05372107View on ClinicalTrials.gov

A Study of AG-80308 in Dry Eye Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

June 13, 2022

Primary Completion Date

November 2, 2022

Study Completion Date

November 2, 2022

Conditions
Dry Eye Disease
Interventions
DRUG

AG-80308

AG-80308 Eye Drop Solution

Trial Locations (3)

84015

Alpine Research Organization, Inc., Clinton

92663

Eye Research Foundation, Newport Beach

02767

Andover Eye Associates, Raynham

Sponsors
All Listed Sponsors
collaborator

ORA, Inc.

INDUSTRY

lead

Allgenesis Biotherapeutics Inc.

INDUSTRY

NCT05372107 - A Study of AG-80308 in Dry Eye Patients | Biotech Hunter | Biotech Hunter